DNLI Denali Total Business Assets
Denali Therapeutics (DNLI) relies on external capital and partnership payments due to a lack of profitable products. High development costs in the CNS field and the risk of technological obsolescence create significant barriers. Future revenues are based on therapies for Alzheimer's and Parkinson's diseases. This chart on GURU.Markets contains an analysis of total assets (via ROA), and the 1162.12 level captures the company's current resource state.
Analytical breakdowns and data insights for company Denali Therapeutics Inc (DNLI)
- current quotes and average value forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Denali Therapeutics|DNLI - Long-Term Debt to Equity|Current Liabilities to Capital Denali Corp|DNLI - Company Aggregate Debts|Debt to Book Value Ratio Denali Corp|DNLI - Company Long-Term Debts|Short-Term Debt Denali Therapeutics|Immediate Liquidity Ratio denalitherapeutics.com
- company profitability and valuation multiples indicators:
Fundamental valuation:denalitherapeutics.com
Investors must weigh the return potential of Denali Therapeutics (DNLI) against the high risks of clinical trial failure stemming from the complexity of crossing the blood-brain barrier. By analyzing total assets via reverse ROA, one can assess resource dynamics and debt load, where a shrinking asset base would indicate either cost optimization or a critical dependence on external financing and partnerships.
Direct competitors
BIIB - Company Total Asset Base|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Harmony Pharma (HRMY) - Aggregate Company Assets|Company Assets Biohaven Corp (BHVN)|AMLX (Amylyx Pharmaceuticals) - Company Total Assets|Total Business Assets TRVI (trevitherapeutics.com)|Company Total Assets PRAX|AVXL - Company Assets|Aggregate Company Assets CeriBell Corp CBLL|PRTA: Total Business Assets|Alector Therapeutics - Company Total Assets|ANNX - Company Total Assets|omeros.com (OMER) - Aggregate Company Assets|NGNE (Neurogene Inc) - Aggregate Company Assets|ACIU (AC Immune Corp) - Company Total Assets|Voyager Corp (VYGR) - Company Total Asset Base|Cumulative Company Assets NMRA (Neumora Therapeutics)|SCLX (scilexholding.com) - Aggregate Asset Value|Tevogen Bio - Cumulative Company Assets|Aggregate Business Assets ACOG (Alpha Cognition Inc)|Cognition Therapeutics, Inc. - Company Total Assets|Aggregate Asset Value IKT (Inhibikase Pharma)|SAVA: Company Total Assets|Company Assets Assertio (ASRT)|Aggregate Company Assets Coya Therapeutics Inc|VTGN: Aggregate Asset Value|Company Total Assets OVID|Company Total Assets Acumen Pharmaceuticals, Inc (ABOS)|Aggregate Company Assets CervoMed Inc. CRVO|ATHE (Alterity Therapeutics Ltd.) - Total Asset Value of Company|Clene Nanomedicine - Company Total Assets|Company Assets PepGen Inc.|JUNS (Jupiter Neurosciences) - Cumulative Company Assets|Relmada Corp (RLMD) - Company Total Assets|Cumulative Company Assets ANVS|GRCE (Grace Tx) - Aggregate Business Assets|Company Total Assets AIFF|Company Total Asset Base anewmeds.com|Company Total Assets NRSN (NeuroSense Therapeutics Ltd.)|RVPH - Cumulative Company Assets|MTVA - Aggregate Company Assets|Company Total Asset Base neuraxis.com NRXS|HSDT: Company Total Assets|Total Business Assets PASG|Aggregate Company Assets Neuphoria Therapeutics, Inc.|Total Business Assets NERV (Minerva)|Aggregate Company Assets Athira Pharma, Inc. (ATHA)|Aggregate Company Assets ADXN (addextherapeutics.com)|Company Total Assets ALZN (Alzamend Neuro)|Company Total Asset Base Cyclerion Therapeutics Inc. (CYCN)|PTIX - Aggregate Company Assets|KTTA (Pasithea Therapeutics) - Total Business Assets|CRGT: Company Total Assets|Company Assets avenuetx.com (ATXI)|Cumulative Company Assets BCLI|Company Total Assets Cara Therapeutics Inc.|Aggregate Company Assets Chromocell Therapeutics Corporation (CHRO)|ELYM (eliemtx.com) - Aggregate Asset Value|Aggregate Company Assets Intra-Cellular Therapies, Inc. ITCI|longboardpharma.com (LBPH) - Company Assets|Marinus Pharmaceuticals, Inc. - Company Total Assets|NKGN (NKGen Biotech Inc) - Total Business Assets|NRBO: Company Total Assets|Company Assets Sage Therapeutics Inc (SAGE)|Aggregate Company Assets Synaptogenix, Inc.|Total Business Assets TRVN (trevena.com)|Company Total Assets VIGL|Company Total Assets anewmeds.com (WENA)|Aggregate Company Assets Cerevel CERE